Can innovation in endoscopic therapy alter clinical outcomes in patients with familial adenomatous polyposis?
- PMID: 34466371
- PMCID: PMC8382497
- DOI: 10.1055/a-1521-4912
Can innovation in endoscopic therapy alter clinical outcomes in patients with familial adenomatous polyposis?
Conflict of interest statement
Competing interests The authors declare that they have no conflict of interest.
Comment on
-
Prophylactic colectomy and rectal preservation in FAP: systematic endoscopic follow-up and adenoma destruction changes natural history of polyposis.Endosc Int Open. 2021 Jul;9(7):E1014-E1022. doi: 10.1055/a-1467-6257. Epub 2021 Jun 17. Endosc Int Open. 2021. PMID: 34222624 Free PMC article.
References
-
- Vasen H FA, Moslein G, Alonso A et al.Guidelines for the clinical management of familial adenomatous polyposis (FAP) Gut. 2008;57:707–713. - PubMed
-
- Van Leerdam M E, Roos V H, van Hooft J E et al.Endoscopic management of polyposis syndromes; European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2019;51:877–895. - PubMed
-
- Monahan K J, Bradshaw N, Dolwani S et al.Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG) Gut. 2020;69:411–444. - PMC - PubMed
-
- Bulow S. Clinical features in familial polyposis coli. Results of the Danish Polyposis Register. Dis Colon Rectum. 1986;29:102–107. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
